Methods of surgery for pelvic organ prolapse in a nationwide cohort (FINPOP 2015).


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
04 2019
Historique:
received: 09 05 2018
accepted: 08 12 2018
pubmed: 24 12 2018
medline: 20 12 2019
entrez: 23 12 2018
Statut: ppublish

Résumé

The management of pelvic organ prolapse (POP) varies significantly between countries. The objective of this study was to describe the methods used for POP surgery in Finland and to identify the factors that affect clinicians' choice to use either a native tissue repair (NTR) or a mesh repair method. This prospective cohort study included 3535 surgeries covering 83% of all POP operations performed in Finland in 2015. The operative details and patient characteristics, including the Pelvic Floor Distress Inventory (PFDI-20), were compared between three selected surgical methods: NTR, transvaginal mesh (TVM) and abdominal mesh (AM). The predictive factors for the use of mesh augmentation were also studied with logistic regression analysis. The most common method was NTR (n = 2855, 81%), followed by TVM (n = 429, 12%) and AM (n = 251, 7%). Approximately 92% of the patients who underwent primary prolapse surgery underwent NTR, and mesh surgery was used mainly for recurrent prolapse. The strongest predictor of mesh surgery was previous POP surgery for the same vaginal compartment (adjusted odds ratio [OR] = 56, 95% confidence interval [CI] = 38-84 for TVM; adjusted OR = 22, 95% CI = 14-34 for AM). Other predictive factors for mesh surgery were previous hysterectomy, healthcare district, severe bulge symptoms and advanced prolapse. TVM was associated with advanced anterior prolapse and older age. AM surgery was associated with advanced apical and/or posterior compartment prolapse. PFDI-20 scores were the highest in the AM group (108 vs 103 in the TVM group and 98 in the NTR group, P = 0.012), which indicates more bothersome symptoms than in the other groups. The Finnish practices follow international guidelines that advocate NTR as the principal surgical method for POP. Synthetic mesh augmentation was mainly used in patients with recurrent and advanced prolapse with severe symptoms. The variation in the rates of mesh augmentation for POP surgery in different hospitals implies a lack of sufficient evidence of the most suitable treatment method and indicates a need for national guidelines.

Identifiants

pubmed: 30578530
doi: 10.1111/aogs.13520
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-459

Subventions

Organisme : Finnish Society of Gynecological Surgery
Pays : International
Organisme : Emil Aaltosen Säätiö
Pays : International
Organisme : Finnish Cultural Foundation
Pays : International
Organisme : Häme Regional Fund
Pays : International
Organisme : Ministry of Health and Social Welfare in Finland
Pays : International
Organisme : Kanta-Häme Central Hospital
Pays : International

Informations de copyright

© 2018 Nordic Federation of Societies of Obstetrics and Gynecology.

Auteurs

Nina K Mattsson (NK)

Department of Obstetrics and Gynecology, Kanta-Häme Central Hospital, Hämeenlinna, Finland.
Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Päivi Karjalainen (P)

Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland.

Anna-Maija Tolppanen (AM)

School of Pharmacy, University of Eastern Finland, Kuopio, Finland.

Anna-Mari Heikkinen (AM)

Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Terveystalo, Kuopio, Finland.

Jyrki Jalkanen (J)

Central Finland Hospital District, Jyväskylä, Finland.
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.

Päivi Härkki (P)

Department of Obstetrics and Gynecology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.

Kari Nieminen (K)

Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH